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Abstract
Background: We wished to compare the San Francisco Syncope Rule (SFSR), Evaluation of Guidelines in Syncope
Study (EGSYS) and the Osservatorio Epidemiologico sulla Sincope nel Lazio (OESIL) risk scores and to assess their
efficacy in recognising patients with syncope at high risk for short-term adverse events (death, the need for major
therapeutic procedures, and early readmission to the hospital). We also wanted to test those variables to designate
a local risk score, the Anatolian Syncope Rule (ASR).
Methods: This prospective, cohort study was conducted at the emergency department of a tertiary care centre.
Between December 1 2009 and December 31 2010, we prospectively collected data on patients of ages 18 and
over who presented to the emergency department with syncope.
Results: We enrolled 231 patients to the study. A univariate analysis found 23 variables that predicted syncope
with adverse events. Dyspnoea, orthostatic hypotension, precipitating cause of syncope, age over 58 years,
congestive heart failure, and electrocardiogram abnormality (termed DO-PACE) were found to predict short-term
serious outcomes by logistic regression analysis and these were used to compose the ASR. The sensitivity of ASR,
OESIL, EGSYS and SFSR for mortality were 100% (0.66 to 1.00); 90% (0.54 to 0.99), 80% (0.44 to 0.97) and 100% (0.66
to 1.00), respectively. The specificity of ASR, OESIL, EGSYS and SFSR for mortality were 78% (0.72 to 0.83); 76% (0.70
to 0.82); 80% (0.74 to 0.85) and 70% (0.63 to 0.76). The sensitivity of ASR, OESIL, EGSYS and SFSR for any adverse
event were 97% (0.85 to 1.00); 70% (0.52 to 0.82); 56% (0.40 to 0.72) and 87% (0.72 to 0.95). The specificity of ASR,
OESIL, EGSYS and SFSR for any adverse event were 72% (0.64 to 0.78); 82% (0.76 to 0.87); 84% (0.78 to 0.89); 78%
(0.71 to 0.83), respectively.
Conclusion: The newly proposed ASR appears to be highly sensitive for identifying patients at risk for short-term
serious outcomes, with scores at least as good as those provided by existing diagnostic rules, and it is easier to
perform at the bedside within the Turkish population. If prospectively validated, it may offer a tool to aid
physicians’ decision-making.
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Syncope is a symptom of cerebral hypoperfusion and is
defined as a short, sudden, self-terminating episode of
transient loss of consciousness with a failure to maintain
postural tone and with a variety of aetiologies. More
than two million people are evaluated for syncope each
year in the US, with the cost running into the billions of
dollars [1]. It accounts for approximately 3% to 5% of
emergency department (ED) visits and, in selected
patient populations, the lifetime prevalence of syncope
could reach almost 50% [2,3].
Patients with syncope pose a difficult diagnostic
dilemma. Most patients appear well and are asympto-
matic on arrival, and there are often no witnesses to the
event. Some patients will require emergency hospitalisa-
tion for a workup and for the treatment of life-threaten-
ing or potentially life-threatening causes [4,5]. Even after
extensive inpatient evaluation, an underlying aetiology
remains unknown in 30% to 50% of patients [6].
Clinical decision rules are tools designed to assist clin-
icians in making decisions at the bedside and to risk-
stratify the patients. They are derived from original
research and incorporate important predictors of out-
come from the history, physical examination and basic
diagnostic tests. The Osservatorio Epidemiologico sulla
Sincope nel Lazio (OESIL) risk score, the San Francisco
Syncope Rule (SFSR) and the Evaluation of Guidelines
in Syncope Study (EGSYS) risk scores are largely used
in emergency settings [7-9].
According to the OESIL study group, syncope score pre-
dictors of death after one year are an abnormal electrocar-
diogram (ECG), a history of cardiovascular disease
(including heart failure), age of over 65 years old, and syn-
cope without prodrome. Each risk factor counts as one
point. In keeping with the OESIL study, we considered
those patients who were characterised by a score of up to
1 to be low risk. Patients with a score of 2 or higher were
assumed to be at intermediate or high risk (that is, they
were admitted to the hospital) [7]. The SFSR was derived
and validated to predict adverse outcomes at 7 and 30
days. Significant predictors of adverse events included a
history of heart failure (CHF), an abnormal ECG (nonsinus
rhythm on ECG or during ED monitoring, or new mor-
phological changes on the ECG), a haematocrit of less
than 30%, a complaint of shortness of breath, and a systo-
lic blood pressure of less than 90 mmHg at triage [8].
According to the EGSYS research group, score factors
associated with cardiac syncope include an abnormal
ECG, a history of heart disease, palpitations prior to syn-
cope, syncope while supine or during exertion, and the
absence of an autonomic prodrome [9].
The aim of the present study was to compare the
SFSR, the OESIL risk score and the EGSYS risk score to
assess their efficacy in recognising patients with syncope
at high risk for short-term (within seven days) adverse
events (that is, death, the need for major therapeutic
procedures, or early readmission to the hospital) and to
test those variables to designate a local risk score,
termed the Anatolian Syncope Rule (ASR). To the best
of our knowledge, no comparative study for the Turkish
population regarding the use of three clinical decision
rules for syncope in a 7-day period and no proposed
new decision rule have previously been published.
Methods
This observational, single-centre, prospective cohort
study was conducted in the ED of a research and train-
ing hospital. During a 13-month period, between
December 1 2009 and December 31 2010, we prospec-
tively collected data on patients who presented to the
ED with syncope.
Patients were screened at triage on the basis of the
following symptoms, findings and complaints for a
potential syncopal event: syncope, loss of consciousness,
presyncope, fainting, collapse, light-headedness, dizzi-
ness, falls, seizures, head injury and bone fractures. A
research paramedic, who was blinded to the study pro-
tocol, ensured enrolment of all potential syncopal
events. A patient evaluation form with the name of the
patient written on it was brought to one of the five
research physicians. The exclusion criteria used to deter-
mine the target population were as follows:
1. age below18;
2. unable to give either written or verbal informed
consent;
3. confirmed nonsyncopal syndromes such as vertigo,
coma, shock, witnessed seizure, sustained unconscious-
ness, head injury preceding loss of consciousness, stroke;
4. unable or unfeasible to follow-up (out of town resi-
dents, homeless);
5. presence of a clinical condition that required admis-
sion, such as acute myocardial infarction, pulmonary
embolism, intracranial haemorrhage, sustained sympto-
matic bradycardia and tachycardia;
6. comorbidities with low survival rate;
7. pregnancy;
8. history of drug or alcohol abuse.
The final decision to enrol the patient was made by
the research physicians and they completed the patient
evaluation forms, containing approximately 70 variables
that were derived from existing syncope rules, patient
history, vital signs and physical examination. Where
possible, attending physicians independently evaluated
patients to measure agreement on subjective variables
requiring interpretation. Only the attending physician
assessments were used in the analysis and derivation of
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by the attending physicians, who were blinded to the
study protocol.
As shown in Figure 1, a total of 1,271 consecutive
patients were screened and 251 patients were enrolled.
Twenty patients were lost to follow-up and 231 patients
were eligible for the study.
The primary end-point of our study was the presence
of any adverse event within seven days of discharge
from the hospital, which included rehospitalisation, a
major therapeutic intervention or death. No exceptions
were made for these criteria. All discharged and
admitted patients or their tutors were surveyed on
seventh day of the index event by follow-up examination
o ri n t e r v i e wa n dt h ep r e s e n c eo fa n ya d v e r s ee v e n tw a s
sought.
A major therapeutic intervention was defined as cardi-
opulmonary resuscitation, pacemaker or implantable
cardioverter-defibrillator insertion, intensive care unit
admittance or acute antiarrhythmic therapy. An ECG
was defined as abnormal in the presence of any of the
following in keeping with the criteria used in OESIL risk
score: atrial fibrillation or tachycardia; a sinus pause of
two seconds or more; sinus bradycardia with a heart
rate ranging between 35 and 45 beats per minute; con-
duction disorders; ECG signs of previous myocardial
infarction or ventricular hypertrophy; or multiple pre-
mature ventricular beats [10]. The ECG was analysed by
the cardiologist on duty, who was unaware of the study
and blinded to the three risk scores. We considered an
ECG as abnormal independent of the onset time. Ortho-
static hypotension was defined as a decrease of at least
20 mmHg in the systolic blood pressure or at least 10
mmHg in the diastolic blood pressure within two min-
utes of standing [6].
The study was approved by the Ethical Committee on
Human Research of the Coordinating Centre, and parti-
cipants provided written consent.
Statistical analysis
SPSS version 15 (IBM, New York, USA) was used for
descriptive data analysis. All continuous variables are
presented as means with standard deviation (SD). Cate-
gorical variables are presented as percentages with 95%
confidence intervals (CIs). A Pearson’s chi-squared or
Fisher’s exact test was used for categorical variables, and
a Student’s t-test was used for continuous variables. To
develop a score predictive of high-risk patients, binary
variables were created from continuous variables. Uni-
v a r i a t ep r e d i c t o r so fh i g h - r i s ks y n c o p ew e r ei d e n t i f i e d
by chi-squared analysis. Variables with a high univariate
correlation and with P < 0.10 were considered in step-
wise logistic regression analyses with a cut-off P-value of
< 0.05. Variables with similar meaning were combined
to reduce the number of variables to be included in the
logistic regression analysis (Table 1).
Multivariable logistic regression analysis was then used
to model the independent associations, demographic
factors and whether any adverse event had happened,
while controlling for sex and age as possible confoun-
ders. The goodness-of-fit for this regression model at
each variable was verified by the Hosmer-Lemeshow
test. The proportion of variance explained by the final
model was determined using the Nagelkerke R statistics.
The results of the multivariable logistic regression analy-
sis were used to develop a risk score to predict the
probability of any adverse event in seven days, named
the ASR (Table 2). The relative associations of each
variable as represented by their respective risk ratios
were used to derive ASR (Table 2). Positive or negative
values were assigned to each variable based on the rela-
tive magnitude of the regression coefficient. Then, the
discriminative ability (ability of the score to classify
patients and overall predictive performance) of the
newly proposed ASR was calculated by measuring the
area under the receiver operating characteristic (ROC)
curve (AUC).
We compared the prognostic accuracy of ASR and
other risk scores by generating ROC curves and com-
paring the AUC using the method described by Hanley
and McNeil for comparing ROC curves derived from
the same cases (MedCalc Software version 10.4.0.0;
MedCalc, Mariakerke, Belgium). When assessing poten-
tial decision thresholds in each respective risk score, our
Figure 1 Study population.
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intervention or death at the highest possible specificity.
According to this criterion, we dichotomized ASR as
high- and low-risk values from the decided thresholds
for any adverse event and for mortality. Then, we calcu-
lated sensitivity, specificity, positive predictive value,
negative predictive value, positive likelihood ratio and
negative likelihood ratio values for any adverse events
for each syncope criterion, including the criteria that we
had defined (ASR). To determine the concordance of
high- and low-risk criteria with the presence of any
adverse event, kappa values for each criterion were
calculated.
A two-tailed P < 0.05 was considered to be statistically
significant for all analyses.
Results
Six parameters (presence of dyspnoea, orthostatic
hypotension, any precipitating cause of syncope, age
over 58 years old, presence of congestive heart failure,
and ECG abnormality) were found to have significant
predictive value according to logistic regression
Table 1 Predictors of high-risk syncope on univariate analysis in the derivation cohort (n = 231)
Variable Syncope without adverse events (n = 192)
N (%)
Syncope with adverse events (n = 39)
N (%)
P
Age > 58 68 (35.4) 32 (82.1) < 0.001
Presence of tachycardia 23 (11.9) 9 (23.0) > 0.05
Presence of tachypnea 5 (2.6) 9 (23.1) < 0.001
Ortostatism 6 (3.1) 8 (20.5) < 0.001
Co-morbidity 91 (47.4) 33 (84.6) < 0.001
Polypharmacy 77 (40.1) 31 (78.5) < 0.001
Abnormal physical examination finding 17 (8.9) 13 (33.3) < 0.001
History of coronary artery disease 19 (9.9) 11 (28.2) < 0.005
Presence of a prodrome 37 (19.3) 19 (48.7) < 0.001
Abnormal ECG 31 (16.1) 28 (71.8) < 0.001
History of congestive heart failure 9 (4.7) 13 (33.3) < 0.001
Haematocrit < 30% 6 (3.1) 6 (15.4) < 0.01
Presence of dyspnea 3 (1.6) 7 (17.9) < 0.001
Presence of palpitations 15 (7.8) 8 (20.5) < 0.05
Syncope on exertion 13 (6.8) 10 (25.6) < 0.005
Syncope when supine 5 (2.6) 7 (17.9) < 0.001
Any positive finding on auscultation 4 (2.1) 8 (20.5) < 0.001
Abnormal ECG rhythm 8 (4.2) 8 (20.5) < 0.005
Wide QRS 2 (1.0) 5 (12.8) < 0.005
Abnormal ST (depression/elevation) 3 (1.6) 6 (15.4) < 0.001
Abnormal cardiac axis on ECG 10 (5.2) 7 (17.9) < 0.05
Presence of atrioventricular block 4 (2.1) 7 (17.9) < 0.001
Known precipitating cause for syncope 96 (50) 34 (87.2) < 0.001
ECG: electrocardiogram
Table 2 Predictors of high-risk syncope from multivariate analysis with constant values of logistic regression and
point scores for each predictor
Variable P Regression coefficient
B (standard error)
Risk ratios Score
(Constant) < 0.001 -5.03 (0.72)
Dyspnoea < 0.005 3.04 (0.97) 4.83 1
Ortostatism < 0.05 1.60 (0.80) 4 1
Precipitating cause for syncope < 0.005 1.78 (0.61) 5.28 1
Age > 58 < 0.05 1.45 (0.58) 5.99 1
Congestive heart failure history < 0.05 1.47 (0.61) 4.75 1
Electrocardiogram < 0.001 1.72 (0.53) 7.42 2
Note: R
2 = 0.33 (Cox and Snell), 0.56 (Nagelkerke). Model Chi-square (1) = 93.08, P < 0.001.
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nic, DO-PACE, to compose the newly proposed ASR
(Table 2). Precipitating factors were drugs, diabetes
and neurologic disorders in patients with orthostatic
syncope (40% of the known precipitating group). Fever,
dehydratation, fasting and long standing were the pre-
cipitating factors in vasovagal syncope (45% of the
known precipitating group). The other 15% were due
to arrhythmia and cardiogenic causes. Figure 2 shows
the ROC analysis of the newly proposed ASR scores
for adverse events in syncope derived from the risk
ratios. The AUC was 0.909 (95% CI: 0.864 to 0.942),
indicating a good discriminant ability. A point score >
1 was considered the best discriminator for a diagnosis
of high-risk syncope. The newly proposed ASR per-
formed better, with a higher kappa scores and higher
sensitivity (Table 3). The same calculations were per-
formed to detect the discriminative power of each cri-
terion when predicting mortality (Table 4). The AUC
was 0.927 (95% CI: 0.885 to 0.957), indicating good
discriminant ability. A points c o r e>2w a sc o n s i d e r e d
the best discriminator for a diagnosis of high-risk syn-
cope that resulted in mortality. The newly proposed
ASR performed with higher sensitivity but lower speci-
ficity when predicting mortality, assuming a cut-off
score > 1. However, ROC analysis (Figure 3) showed
that the cut-off value with the highest discriminative
ability was > 2 for mortality (Table 4). With this new
cut-off for mortality, the newly proposed ASR outper-
formed the other diagnostic criteria.
Discussion
Despite the limitations of our study, to the best of our
knowledge this is the first reported cohort study of syn-
cope patients to compare all three clinical rules and the
only attempt to propose a clinical decision rule to iden-
tify high-risk patients from the Turkish population. The
predictor variables used in the evaluation of patients
with syncope developed a highly sensitive clinical deci-
sion rule that we believe will augment physician judge-
ment and allow physicians to decide rationally which
patients with syncope need admission according to their
risk for short-term serious outcomes. The rule is not
complex and easily remembered by a simple mnemonic:
DO-PACE (Dyspnoea, Orthostatic hypotension, Precipi-
tating cause of syncope, Age over 58 years old, Conges-
tive heart failure, and ECG abnormality).
The demographic variables of age, sex, and race are
potential risk factors for cardiovascular disease. Epide-
miologic and cohort studies have confirmed the impor-
tance of age; however, of course, age alone is a marker
for increased mortality. Although increasing age is
accompanied by an increased risk of poor outcomes,
there is no single cut-off for age but rather a continuum
of gradually increasing risk [11-13]. The OESIL study
found that an age of over 65 years is one of the predic-
tors. However, in our decision rule, an age of over 58
years is one of the predictors of high-risk syncope. We
used ROC analysis to find the best age cut-off to discri-
minate between having an adverse event or not. Age 58
years was found to have the highest accuracy with the
highest sensitivity and specificity and therefore was cho-
sen to be the cut-off of the newly proposed ASR (sensi-
tivity 82.05% (95% CI: 66.5 to 92.5); specificity 64.58%
(95% CI: 57.4 to 71.3)). If we had used the age of 65 as
the cut-off in our study, as in the OESIL study, our sen-
sitivity would have dropped, and specificity would have
increased (sensitivity 56.41% (95% CI: 39.6 to 72.2); spe-
cificity 73.96% (95% CI: 67.1 to 80.0)). Additionally, we
would have misgrouped 11 patients (22.4% of the
patients with any adverse event) as low risk. To include
any patient with any adverse event, the cut-off age to be
chosen would have been 40 (sensitivity 100.00% (95%
CI: 91.0 to 100.0); specificity 38.02% (95% CI: 31.1 to
45.3)). However, we would have grouped seven more
patients correctly as high risk (14%) at the expense of
grouping 53 patients (27.6% of the patients without any
adverse events) as high risk when they actually were
not. Nevertheless, there were no high-risk patients
between the ages of 40 and 58 years old who were mis-
grouped as low risk just because of their ages. All of the
patients who ended up with adverse events had another
positive risk factor, other than their age, that grouped
them into the high-risk category according to the newly
Figure 2 Receiver operating characteristic analysis for
predicting any adverse event. ROC analysis of the newly
proposed Anatolian Syncope Rule in the cohort for predicting any
adverse event. Dotted lines define the 95% confidence intervals.
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was the best-fit cut-off for our purposes, and when used
in the newly proposed ASR, the diagnostic abilities are
the same as when either 40 or 58 years old is chosen as
a cut-off.
Orthostatic hypotension may identify some patients
with syncope related to volume depletion, autonomic
insufficiency or medications. Orthostatic hypotension is
common in patients with syncope of unknown aetiology,
and this finding is also present in up to 40% of asympto-
matic patients older than 70 years old and 23% of those
patients younger than 60 years old [14]. A diagnosis of
orthostatic hypotension should be a diagnosis of exclu-
sion in otherwise low-risk patients, with the realisation
that many high-risk patients will have orthostasis [15].
In our cohort, orthostatic hypotension was one of the
Table 3 Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative
likelihood ratio and Kappa values for each syncope criteria for any adverse event
OESIL
(95% CI)
SFSR
(95% CI)
EGSYS
(95% CI)
ASR
(95% CI)
Sensitivity 0.70
(0.52 to 0.82)
0.87
(0.72 to 0.95)
0.56
(0.40 to 0.72)
0.97
(0.85 to 1.00)
Specificity 0.82
(0.76 to 0.87)
0.78
(0.71 to 0.83)
0.84
(0.78 to 0.89)
0.72
(0.64 to 0.78)
True positive
(PPV)
0.44
(0.32 to 0.57)
0.44
(0.33 to 0.56)
0.42
(0.29 to 0.57)
0.41
(0.31 to 0.52)
False positive 0.56
(0.42 to 0.68)
0.56
(0.44 to 0.67)
0.57
(0.43 to 0.71)
0.59
(0.48 to 0.68)
True negative
(NPV)
0.93
(0.88 to 0.96)
0.97
(0.92 to 0.99)
0.91
(0.85 to 0.94)
0.99
(0.95 to 1.00)
False negative 0.07
(0.04 to 0.12)
0,03
(0.01 to 0.08)
0.09
(0.06 to 0.15)
0.007
(0.00 to 0.05)
Positive LR 3.91
(2.70-5.66)
3.89
(2.91-5.20)
3.61
(2.35-5.55)
3.46
(2.75-4.37)
Negative LR 0.37
(0.23-0.60)
0.17
(0.07-0.38)
0.52
(0.36-0.74)
0.03
(0.005-0.25)
Kappa for adverse events 0.44 0.52 0.37 0.53
ASR: Anatolian Syncope Rule; CI: confidence interval; EGSYS: Evaluation of Guidelines in Syncope Study; LR: likelihood ratio; NPV: negative predictive value; OESIL:
Osservatorio Epidemiologico sulla Sincope nel Lazio; PPV: positive predictive value; SFSR: San Francisco Syncope Rule.
Table 4 Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative
likelihood ratio and Kappa values for each syncope criteria for mortality
OESIL
(95% CI)
SFSR
(95% CI)
EGSYS
(95% CI)
ASR > 1
(95% CI)
ASR > 2
(95% CI)
Sensitivity 0.90
(0.54 to 0.99)
1
(0.66 to 1.00)
0.80
(0.44 to 0.97)
1
(0.66 to 1)
1
(0.66 to 1)
Specificity 0.76
(0.70 to 0.82)
0.70
(0.63 to 0.76)
0.80
(0.74 to 0.85)
0.63
(0.56 to 0.69)
0.78
(0.72 to 0.83)
True positive
(PPV)
0.15
(0.07 to 0.27)
0.13
(0.07 to 0.23)
0.15
(0.07 to 0.29)
0.11
(0.06 to 0.20)
0.17
(0.09 to 0.30)
False positive 0.85
(0.74 to 0.93)
0.87
(0.77 to 0.93)
0.85
(0.71 to 0.93)
0.89
(0.80 to 0.94)
0.83
(0.70 to 0.91)
True negative
(NPV)
0.99
(0.96 to 1.00)
1
(0.97 to 1.00)
0.99
(0.96 to 1.00)
1
(0.97 to 1)
1
(0.97 to 1)
False negative 0.006
(0.00 to 0.04)
0
(0.00 to 0.03)
0.01
(0.00 to 0.04)
0
(0 to 0.03)
0
(0 to 0.03)
Positive LR 3.83
(2.79 to 5.24)
3.30
(2.70 to 4.03)
4.02
(2.67 to 6.04)
2.70
(2.27 to 3.20)
4.60
(3.58 to 5.91)
Negative LR 0.13
(0.02 to 0.84)
0
(0 to 0)
0.25
(0.07 to 0.86)
0
(0 to 0)
0
(0 to 0)
Kappa for
mortality
0.31 0.30 0.29 0.26 0.37
ASR: Anatolian Syncope Rule; CI: confidence interval; EGSYS: Evaluation of Guidelines in Syncope Study; LR: likelihood ratio; NPV: negative predictive value; OESIL:
Osservatorio Epidemiologico sulla Sincope nel Lazio; PPV: positive predictive value; SFSR: San Francisco Syncope Rule.
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multivariate analysis that had not been described before
in any other decision rule.
Sarasin et al. showed that, in patients with syncope,
ST-segment and T-wave abnormalities were one of the
significant predictors of arrhythmias [16]. In another
study, the presence of an abnormal ECG, excluding a
nonspecific ST-segment and T-wave changes, was a
multivariate predictor for arrhythmia or death within
one year after the syncopal episode [17]. Arrhythmia-
related syncope is diagnosed by ECG when there is
sinus bradycardia < 40 beats/min or repetitive sinoatrial
blocks or sinus pauses > 3 sec; a Mobitz II 2nd- or 3rd-
degree atrioventricular block; an alternating left and
right bundle branch block; a rapid paroxysmal supraven-
tricular tachycardia or ventricular tachycardia; or pace-
maker malfunction with cardiac pauses [18]. In our
study, tachycardia, the presence of palpitations, an
abnormal ECG or abnormal rhythm, a wide QRS com-
plex, an abnormal ST deviation, an abnormal cardiac
axis and the presence of an atrioventricular block were
the predictors of high-risk syncope in univariate analy-
sis. We combined all ECG-related predictors into one,
and ‘abnormal ECG’ defines all of them in the logistic
regression analysis.
In a prospective study in Europe of 676 patients with
syncope, predictors of short-term unfavourable outcome
at 10 days included a mean age of 59 years old, abnor-
mal ECG findings, concomitant trauma, an absence of
prodromal symptoms and male sex. The occurrence of
long-term unfavourable outcome was correlated with an
age older than 65 years, a history of neoplasms, cerebro-
vascular disease, structural heart diseases and ventricular
arrhythmias. These investigators concluded that risk fac-
tors for short- and long-term adverse outcomes after
syncope were different and that long-term mortality was
related to the comorbidities. Significant independent
prognostic factors for time to mortality were diabetes,
coronary artery bypass graft surgery, a history of malig-
nancy, narcotics use, smoking, volume depletion and
atrial fibrillation [19]. In our study, the presence of pro-
dromal symptoms, coronary artery disease and conges-
tive heart disease were the predictors of high-risk
syncope in univariate analysis.
A recent study by Quinn et al. defined multiple uni-
variate predictors of serious outcomes that included an
abnormal ECG, a haematocrit of less than 30%, a com-
plaint of shortness of breath, hypotension and a prior
history of congestive heart failure [7,12]. In our study,
tachypnoea, dyspnoea and history of congestive heart
failure were the predictors of high risk and were corre-
lated with the literature.
An absent or brief prodrome (less than 5 seconds)
may be present with dysrhythmias, whereas neurally
mediated syncope (synonyms include neurocardiogenic
syncope and vasovagal syncope) may be characterised by
longer prodromes and associated with nausea or vomit-
ing [11].
When developing any prediction rule, one can always
achieve 100% sensitivity but often at the expense of spe-
cificity and by overfitting of the statistical model. For
example, in our model, we could have achieved 100%
sensitivity by adding an age older than 40 years old to
the rule, which would have identified the seven patients
not predicted by the rule. We thought that the trade-off
was suboptimal because the absolute admission rate for
patients deemed to be high risk would be the same as, if
not slightly higher than, at baseline. We were also aware
that rare, serious outcomes not in our derivation set
would make validating any rule with 100% sensitivity
and certainty almost impossible. We thus accepted a
rule that maximised sensitivity and specificity at the
expense of not achieving 100% sensitivity. We purposely
did not develop the rule with the physician’sd e c i s i o n -
to-admit as the primary outcome. Thus, this rule is not
a decision rule to predict admission. The reasons to
admit often take other factors (for example, social fac-
tors) into consideration that, although important, we
believed were not specific to whether patients with syn-
cope are at an acute risk for serious outcomes that
require acute hospitalisation.
Study limitations
Our study has some limitations. First of all, power cal-
culations were not made prior to commencement of the
study because there were no published articles to guide
our three-way comparison. This was a single-centre
Figure 3 Receiver operating characteristic analysis for
predicting any mortality. ROC analysis of the newly proposed
Anatolian Syncope Rule in the cohort for predicting any mortality.
Dotted lines define the 95% confidence intervals.
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whole Turkish population. Attending physicians
reviewed all cases independently and the decisions of
attending physicians superseded in case of dispute.
However, inter-rater reliability of all subjective findings
was reasonable, fair or worse with kappa values of 0.5 or
less. So we decided to accept attending senior physi-
cians’ decisions for the analysis and derivation of the
model.
Conclusions
This prospective cohort study has shown that many
variables included here, but not described before, are
associated with serious outcomes in patients with syn-
cope. SFSR performed better in the prediction process
of any short-term adverse events. SFSR also had the
best score to rule-out short-term mortality. However,
none of these scores either rule-in or rule-out any
short-term adverse events or mortality well enough to
be suggested. The newly proposed ASR appears to be
highly sensitive for identifying patients at risk for short-
term serious outcomes, at least as good as other scores,
and it is easier to perform at the bedside for the Turkish
population. If prospectively validated, it may offer a tool
to aid physicians’ decision-making. Our proposed deci-
sion rule now needs to be validated prospectively in a
large cohort of patients before physicians can consider it
in clinical decision-making.
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